Potency and suppurative adenitis in BCG vaccination.
Studies performed up to now in animal and man show that potent BCG strains guarantee a higher protection against tuberculosis than strains with weak virulence. Vaccine prepared from a strong BCG strain may be administered in lower doses, reducing the incidence of suppurative adenitis to a level acceptable by the individual patients and the health authorities.
D001500:BCG Vaccine / Q000009:adverse effects*; D006801:Humans; D007109:Immunity; D007223:Infant; D007231:Infant, Newborn; D008199:Lymphadenitis / Q000209:etiology* / Q000517:prevention & control; D009163:Mycobacterium bovis / Q000276:immunology*; D014376:Tuberculosis / Q000517:prevention & control
D001500:BCG Vaccine